Sep 13, 2024 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Valeo Pharma, Inc. third-quarter results (spoken in foreign language) conference call. (Operator Instructions) This call is being recorded on Friday, September 13, 2024. I would now like to turn the conference over to Frederic Dumais, Director of Communications and Investor Relations. Please go ahead.
Frederic Dumais - Valeo Pharma Inc - Director Communications and Investor Relations
Thank you, operator. Good morning, everyone. Present with me today for our third quarter 2024 financial results call are Mr. Al Moghaddam, our CEO; and Mr. Pascal Tougas, our Chief Financial Officer. Before we begin our call, I would like to remind everyone that this conference call may contain certain forward-looking statements regarding the company's expectations or future events.
Such expectations are based on certain assumptions that are founded on currently available information, as these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements
Q3 2024 Valeo Pharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot